Charley Beever
Vice President, Booz & Company

A New York-based GBC Partner, Booz & Company's Charley Beever leads efforts to serve pharmaceutical clients worldwide. He has more than 25 years of experience working with leading U.S., European, and Japan-based pharmaceutical, biotechnology, diagnostic, healthcare, and medical device/supply companies to initiate and resolve strategic, organizational, growth and performance improvement issues. A recognized thought leader, Beever contributed to the articles: "U.S. Health Care’s Technology Cost Crisis," "The Prescription for Drug Costs," "What’s Driving Prescription Drug Costs?," and "Patient Safety: A Data-Driven Prescription," as well as Booz & Company studies “The Global AIDS Crisis—A Strategic Simulation to Explore Public/Private Partnerships in the Fight against HIV/AIDS” and “The Cost of Medical Technologies—Maximizing the Value of Innovation."
Associated Sessions
Entry-Points for Business in Obama’s New Global Health Initiative


All Access Pass
| Individual: | $2,500 |
Individual all access passes include a ticket to the awards dinner, access to the pre-Awards Dinner cocktail reception, and one full conference registration.
Conference Only
| GBC Non-Members: | $695 |
| GBC Members: | $550 |
| Nonprofits: | $295 |
Fees include access to all sessions, breakfast and lunch plenaries and the conference cocktail reception.
Sponsorship
Sponsors receive complimentary conference passes, complimentary awards dinner tickets, and access to the pre-Awards Dinner cocktail reception.
Follow us for the latest conference updates, including newly confirmed speakers and sessions.














